Sonova reported mixed H1 results. While the top line continued to grow and the 2022/23 guidance was reiterated, the management is now targeting the lower end of guidance due to macro-economic headwinds. Fortunately, healthy developments in HI (lynch-pin segment) were reassuring, including the positive response to the newly-launched Lumity platform. Moreover, despite near-term restraint being an inevitable reality, share buy-backs (unlike peers) were maintained. Overall, Sonova remains one of our ....
15 Nov 2022
Mixed H1; near-term looks difficult
Sign up to access
Get access to our full offering from over 100 providers
Get access to our full offering from over 100 providers
Mixed H1; near-term looks difficult
Sonova reported mixed H1 results. While the top line continued to grow and the 2022/23 guidance was reiterated, the management is now targeting the lower end of guidance due to macro-economic headwinds. Fortunately, healthy developments in HI (lynch-pin segment) were reassuring, including the positive response to the newly-launched Lumity platform. Moreover, despite near-term restraint being an inevitable reality, share buy-backs (unlike peers) were maintained. Overall, Sonova remains one of our ....